Diabetes und COPD: Gemeinsam oder doch allein?

J. Mahlmeister; C. Schumann; M. Merkel

doi:10.1055/s-0034-1366439

Diabetologie und Stoffwechsel, Table of Contents

Diabetologie und Stoffwechsel 2014; 9(2): 93-95
DOI: 10.1055/s-0034-1366439

Editorial

Diabetes und COPD: Gemeinsam oder doch allein?

Diabetes and COPD: Together or Alone yet?

Authors

J. Mahlmeister

¹Selbständige Abteilung für Allgemeinmedizin, Universität Leipzig Gemeinschaftspraxis Dr. Jarmila Mahlmeister/Anita Conze, Schondra
C. Schumann

²Klinik für Pneumologie, Thoraxonkologie, Schlaf- und Beatmungsmedizin, Klinikverbund Kempten-Oberallgäu gGmbH, Immenstadt
M. Merkel

³1. Medizinische Abteilung (Endokrinologie, Diabetes, Stoffwechsel, Gastroenterologie, Allgemeine Innere Medizin) Asklepios Klinik St. Georg, Hamburg

Abstract

Full Text

References

Literatur
1 International Diabetes Foundation (IDF). IDF Diabetes Atlas. 6th edn. 2013. http://www.idf.org/diabetesatlas
2 Tamayo T, Rathmann W. Epidemiologie des Diabetes – aktuelle Zahlen. Diabetologie 2014; 9: R1-R8
3 Akinbami LJ. Chronic Obstructive Pulmonary Disease Among Adults Aged 18 and Over in the United States, 1998–2009. 2011. 2014; http://www.cdc.gov/nchs/data/databriefs/db63_tables.pdf#1
4 Aumann I, Prenzler A. Epidemiologie und Kosten der COPD in Deutschland – Eine Literaturrecherche zu Prävalenz, Inzidenz und Krankheitskosten. Klinikarzt 2013; 42: 168-172
5 Schnell K, Weiss CO, Lee T et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med 2012; 12: 26
6 Mannino DM, Thorn D, Swensen A et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-969
7 Ehrlich SF, Quesenberry Jr CP, Van Den Eeden SK et al. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010; 33: 55-60
8 Yoshikawa T, Kanazawa H. Association of plasma adiponectin levels with cellular hydration state measured using bioelectrical impedance analysis in patients with COPD. Int J Chron Obstruct Pulmon Dis 2012; 7: 515-521
9 Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008; 454: 463-469
10 Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem 2013; 59: 381-391
11 Persson LJ, Aanerud M, Hiemstra PS et al. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One 2012; 7: e38934
12 Walters JA, Walters EH, Wood-Baker R. Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; CD005374.
13 Salpeter SR, Greyber E, Pasternak GA et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. CD002967. 2010;